Ebol, Ruelita C.

HRN: 06-16-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2023
CEFUROXIME 1.5GM (VIAL)
08/13/2023
08/20/2023
IVT
1.5 Gms
Now Then Q 8 Hrs
S/P LTCS
Waiting Final Action 
08/14/2023
CEFUROXIME 500MG (TAB)
08/14/2023
08/20/2023
PO
500mg
BID
S/p LTCS
Waiting Final Action 
08/16/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/16/2023
08/20/2023
ORAL
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: